Back to Search Start Over

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

Authors :
Pilar Caridad Morata Barrado
Carlos Guijarro Herraiz
Jorge Jesús Martín Cañuelo
J.F. Merino-Torres
Cristina Tejera Pérez
María Ángeles Martínez López
Teresa Rama Martínez
Sergio Cinza-Sanjurjo
Mª Dolores Aicart Bort
C. Brotons
Vicente Pascual Fuster
Emilio Ortega
Tomás Ripoll Vera
Carmen Peinado Adiego
Alberto Cordero
Carlos Jericó Alba
Luis Castilla-Guerra
Francisco Valls-Roca
Pablo Antonio Toledo Frías
Rosa María Sánchez-Hernández
Antonio Pérez Pérez
Ángel Brea Hernando
Juan Girbés Borrás
Miguel Ángel Prieto Díaz
J.M. Mostaza
María Soledad Navas de Solís
Elisa Velasco Valdazo
Estíbaliz Jarauta Simón
Juan Carlos Ferrer García
José Manuel Ruiz Palomar
Francisco M. Morales-Pérez
Julio Sánchez Álvarez
Javier de Juan Bagudá
Núria Muñoz Rivas
Elías Delgado
Manuel Frías Vargas
Ovidio Muñiz Grijalvo
Esther Doiz Artázcoz
Pedro Valdivielso
Adriana Saltijeral Cerezo
Rebeca Reyes García
Manuel Rodríguez Piñero
Beatriz Jiménez Muñoz
Luis Leiva Hernando
Enrique Rodilla Sala
Alfonso Barquilla García
Jose Daniel Mosquera Lozano
Carlos Santos Altozano
Antonio Miguel Hernández Martínez
Alejandro Berenguel Senén
Manuel Gargallo Fernández
María Gloria Cánovas Molina
Julio Antonio Carbayo Herencia
Ignacio Párraga Martínez
Elena Iborra Ortega
Aurora García Lerín
Vicente Ignacio Arrarte Esteban
Vivencio Barrios
Jose Polo García
Manuel Antonio Botana López
Ruth Sánchez Ortiga
Manuel Suárez Tembra
Miguel Brito Banfiel
Ángel Carlos Matía Cubillo
José María Cepeda Rodrigo
Daniel Escribano Pardo
P. Beato
M. Comellas
Inés Gil Gil
R. Campuzano
Martín Ruiz Ortiz
Víctor Rodríguez Sáenz de Buruaga
Agustín Blanco Echevarría
Rosario Lorente Calvo
José Manuel Comas Samper
Sergio Hevia
Natalia de la Fuente
Juan Cosin Sales
Rafael Vidal-Pérez
Virginia Bellido Castañeda
N. Plana
Amelia Carro
Carlos Lahoz
Magdalena León Mazorra
Sergio Martínez Hervas
Maria Seoane Vicente
Melina Vega de Ceniga
M. Antonia Pérez Lázaro
Sergio Jansen Chaparro
Antonio Ruiz García
Isabel Ayala Vigueras
Miren Morillas Bueno
Esther Merino Lanza
Andrés Galarza Tapia
Marta Casañas Martínez
Daiana Ibarretxe Gerediaga
María Durán Martínez
José Antonio Rubio
Óscar Moreno-Pérez
Andrés García León
Luis Estallo Laliena
Eduardo Carrasco Carrasco
Vicente Pallarés-Carratalá
Alberto Zamora Cervantes
Javier Escalada
Juan Carlos Obaya Rebollar
Mercedes Guerra Requena
José Antonio Quindimil Vázquez
Pedro J. Pinés Corrales
Carlos Escobar Cervantes
Lisardo García-Martín
Albert Clarà
Jose María Fernández Rodriguez-Lacin
Miguel Turégano Yedro
Francisco Javier Félix Redondo
Luis Masmiquel
Jacinto Fernández Pardo
Laura Calsina Juscafresa
María Eugenia López Valverde
Eva María Pereira López
Fátima Almagro Múgica
Agustín Medina Falcón
Source :
Revista Clínica Española (English Edition). 222:82-90
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

There is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical practice and to reach a multidisciplinary consensus on the strategies to be followed in order to optimize its identification, treatment, and follow-up.A multidisciplinary consensus following the Delphi methodology.Professionals (n = 130) with extensive experience in PAD participated in this consultation. The results suggest that in order to optimize the control of risk factors, efforts should be aimed at: (1) promoting the involvement and awareness of all specialists in the identification of and screening for the disease; (2) guaranteeing the possibility of evaluating the ankle-brachial index (ABI) in all the medical specialties involved; (3) promoting strategies for patients to quit smoking through the use of drugs, programs, or referrals to specialized units; (4) promoting an appropriate Mediterranean-based diet and the prescription of daily exercise; (5) raising awareness of the importance of ensuring LDL cholesterol values below 70 mg/dL, especially in symptomatic but also in asymptomatic patients (55 mg/dL following the publication of the ESC/EAS guide); (6) recommending the use of antiplatelet therapy in asymptomatic patients with diabetes mellitus (DM) and/or a pathological ABI; and (7) protocolizing the annual evaluation of ABI in high-risk patients.This document presents the 22 agreed-upon strategies which are intended to help professionals optimize multidisciplinary management of PAD risk factors.

Details

ISSN :
22548874
Volume :
222
Database :
OpenAIRE
Journal :
Revista Clínica Española (English Edition)
Accession number :
edsair.doi.dedup.....bee6670dc2c43df3c36b26d32d1b7df6
Full Text :
https://doi.org/10.1016/j.rceng.2020.11.011